Global Health Committee

Ending Diseases of Poverty through Delivery, Discovery and Advocacy

Current Milestones, January 2010

Cambodia

CHC's community-based treatment model for TB, begun in 3 district hospitals in 1994 in Svay Rieng Province, has now been expanded countrywide to cover all 15 million Cambodians through the Cambodian National TB program.
With support from the Annenberg Foundation, CHC expanded access to treatment for multi-drug resistant tuberculosis (MDR-TB) in Cambodia with the goal of universal access to MDR-TB care for all Cambodians, creating a model of community and home-based care, in partnership with the National TB program.
CHC opened the Joseph P. Sullivan Outpatient Center of Excellence for TB and AIDS Care of Children at the Khmer-Soviet Friendship Hospital (KSFH), Phnom Penh’s largest public hospital in August 2009. Outpatient care is provided for more than 400 HIV-positive children, and an accompanying renovation of the pediatric ward has enhanced services for all children at the hospital.
The CHC’s program at the pulmonary ward at the Khmer-Soviet Friendship Hospital in Phnom Penh, which was once a dilapidated ward for destitute adult TB and AIDS patients, has been transformed by CHC into the Center of Excellence for AIDS and TB care in Cambodia and has provided care for over 1000 patients since 2006.
With continued support from the Jolie-Pitt Foundation, CHC’s Maddox Chivan Children’s Center serves more than 700 HIV-infected or -affected children with medical, nutritional, educational, social, and vocational programs.

The CHC-led clinical trial (CAMELIA) supported by the U.S National Institutes of Health, Division of AIDS, and the French Agence Nationale Recherches sur le SIDA has entered its final phase. The results will reveal how to time AIDS and TB drug therapy in co-infected patients and will determine global practice.
CHC’s community based provincial AIDS programs, the first to treat AIDS at the provincial level and to integrate TB and AIDS care in Cambodia, now provide treatment and follow-up for over 4,000 patients.

Ethiopia

After training in Cambodia, Ethiopian doctors began the first-ever treatment program for MDR-TB in Ethiopia under the Global Health Committee name. This new program, has been supported by the Jolie-Pitt Foundation and by drug donations from Eli Lilly & Co.
As of January 2010, 80 patients have received life-saving MDR-TB medicines and care. Planning for National scale-up of this pioneering program with the Ethiopian Ministry of Health is underway.
Architects are designing the Zahara Center for AIDS- and tuberculosis-affected children in the outskirts of Addis Ababa, modeled after the CHC’s successful Maddox Chivan Children’s Center in Cambodia.

CHC/GHC’s Commitment to Care

We deliver free TB and AIDS care to some of the poorest people on earth, because it is unacceptable that people are dying every day from treatable diseases. We strive to provide access to care in war-torn and post-conflict nations, to help restore health and peace.

Ameliorating Malnutrition and Poverty

Partnering for Successful and Sustainable Programs

Enlisting families, communities, National Health Systems and international agencies to create effective and enduring solutions.

Scaling up Success

Building capacity to have a greater impact on health at the national and international levels.

A Critical Role for Clinical and Basic Discovery

Nesting discovery in our clinical care networks improves care now while finding more effective and innovative approaches to treat TB and AIDS.

Advocating for Access to TB and AIDS Drugs for All

Making the case for better care and more research worldwide by exposing the tragedy of TB and AIDS through testimonies, lectures, publications and exhibits.

Click here to download a PDF version of this page